BiotechTube
Home/Passage Bio/Bruce Goldsmith
BG

Bruce Goldsmith

President and Chief Executive Officer

Passage Bio

Therapeutic Areas

NeurologyRare Diseases

Passage Bio Pipeline

DrugIndicationPhase
PBFT02Frontotemporal Dementia with progranulin mutations (FTD-GRN)Phase 1/2
PBGM01Infantile GM1 GangliosidosisPhase 1/2

Leadership Team at Passage Bio

ES
Eliseo Salinas
Former Chief Executive Officer
WC
William Chou
Chief Executive Officer
SK
Simona King
Chief Financial Officer
RM
Richard Morris
General Counsel
View full Passage Bio profile